Experimental and In Silico Approaches to Study Carboxylesterase Substrate Specificity.

Area of Science:

• Biochemistry and Pharmacology
• Enzymology
• Drug Metabolism

Background:

• Human carboxylesterases (CES) are critical enzymes involved in metabolizing endogenous compounds and xenobiotics.
• CES1 and CES2 isoforms are vital in pharmacotherapy, hydrolyzing many drugs and prodrugs.
• Understanding CES substrate specificity is key for predicting drug fate and designing targeted prodrugs.

Purpose of the Study:

• To provide an integrated overview of experimental and computational strategies for studying CES catalytic activity.
• To highlight the synergy between wet-lab and dry-lab approaches in elucidating CES isoform specificity.
• To serve as a resource for researchers investigating CES-mediated drug biotransformation.

Main Methods:

• Experimental methods include using recombinant CES or human tissue microsomes with spectrophotometry and mass spectrometry.
• Computational approaches involve modeling substrate-CES recognition/affinity (docking, MD, binding calculations) and reaction coordinates (QM/MM).
• Combined experimental and computational strategies offer a synergistic approach to understanding CES function.

Main Results:

• Elucidating CES isoform substrate specificity is essential for drug development and personalized medicine.
• Both experimental and computational methods provide complementary insights into CES-mediated catalysis.
• Integrated approaches enhance the understanding of CES enzyme mechanisms.

Conclusions:

• A combined approach using both experimental and computational methods is crucial for a comprehensive understanding of CES enzyme activity.
• This integrated strategy aids in optimizing prodrug design and predicting drug efficacy.
• Further research leveraging these synergistic methods will advance pharmacotherapy and drug discovery.